Chk1-IN-6
Għal riċerka xjentifika biss, mhux għall-pazjenti.
Dettall tal-Prodott
Tags tal-Prodott
| Daqs tal-Pakkett | Disponibbiltà | Prezz (USD) |
Isem Kimiku:
2-Pyridinecarbonitrile, 5-[[4-[(3-amino-3-methylbutyl)amino]-5-(trifluorometil)-2-pirimidinil]amino]-
Kodiċi SMILES:
N#CC1C=CC(NC2N=C(NCCC(C)(N)C)C(C(F)(F)F)=CN=2)=CN=1
Kodiċi InChi:
InChI=1S/C16H18F3N7/c1-15(2,21)5-6-22-13-12(16(17,18)19)9-24-14(26-1 3)25-11-4-3-10(7-20)23-8-11/h3-4,8-9H,5-6,21H2,1-2H3,(H2,22,24,25,26 )
InChi Key:
QCHCXIAOYLDHOY-UHFFFAOYSA-N
Keyword:
2428423-77-0;CAS:2428423-77-0;CAS:2428423-77-0;Chk1-IN-6
Solubilità:
Ħażna:
Deskrizzjoni:
Chk1-IN-6 huwa inibitur kandidat CHK1 qawwi, selettiv u bijodisponibbli oralment.
Mira: CHK1






![tert-butil (S)-4-(7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)-2-oxo-1,2-dihydropyrido[2,3-d] pirimidin-4-yl)-3-methylpiperazine-1-carboxylate](http://www.caerulumpharm.com/uploads/微信截图_20220803105408.png)
